ASX - By Stock
|
VR1 |
Re:
Ann: VR Space Travel, Gaming & Education Agreement
|
|
Mghunium
|
46 |
17K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
17K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2023
|
|
Mghunium
|
64 |
24K |
6 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
64
|
24K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
11 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
9 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
3 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
Mghunium
|
43 |
17K |
3 |
29/10/22 |
29/10/22 |
ASX - By Stock
|
43
|
17K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
Mghunium
|
43 |
17K |
2 |
29/10/22 |
29/10/22 |
ASX - By Stock
|
43
|
17K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2023
|
|
Mghunium
|
43 |
17K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical releases CT LVAS in Australia
|
|
Mghunium
|
12 |
4.8K |
3 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
12
|
4.8K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical releases CT LVAS in Australia
|
|
Mghunium
|
12 |
4.8K |
8 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
12
|
4.8K
|
8
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Partnership with ESM.ONE Inc
|
|
Mghunium
|
48 |
15K |
2 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
48
|
15K
|
2
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical progresses towards full reimbursement in the US
|
|
Mghunium
|
16 |
8.8K |
6 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
16
|
8.8K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
Digital Health Awards 2022
|
|
Mghunium
|
3 |
1.3K |
7 |
09/10/22 |
09/10/22 |
ASX - By Stock
|
3
|
1.3K
|
7
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Partnership with ESM.ONE Inc
|
|
Mghunium
|
48 |
15K |
10 |
08/10/22 |
08/10/22 |
ASX - By Stock
|
48
|
15K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
4 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
13 |
11/09/22 |
11/09/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
13
|
|
ASX - By Stock
|
LU7 |
Re:
GERNOT
|
|
Mghunium
|
144 |
44K |
7 |
09/09/22 |
09/09/22 |
ASX - By Stock
|
144
|
44K
|
7
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Mghunium
|
51 |
19K |
9 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Mghunium
|
51 |
19K |
0 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Vanderblit 'burn pit' trial hits primary endpoint
|
|
Mghunium
|
51 |
19K |
7 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
51
|
19K
|
7
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Research Grant For Deoxymabs in Metastatic Breast Cancer
|
|
Mghunium
|
10 |
4.1K |
2 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
10
|
4.1K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Half-Year Investor Presentation
|
|
Mghunium
|
64 |
24K |
1 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
64
|
24K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
9 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
9
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Director Resignation
|
|
Mghunium
|
23 |
8.0K |
6 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
23
|
8.0K
|
6
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
Mghunium
|
53 |
24K |
8 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
53
|
24K
|
8
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
Mghunium
|
53 |
24K |
6 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
53
|
24K
|
6
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
Mghunium
|
3.8K |
1.5M |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
3.8K
|
1.5M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
Mghunium
|
3.8K |
1.5M |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
3.8K
|
1.5M
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Sleep Analysis Depressive Burden Study Clinical Trial
|
|
Mghunium
|
29 |
9.5K |
0 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
29
|
9.5K
|
0
|
|
ASX - By Stock
|
AHI |
Re:
AHI Nasdaq Delisting Party
|
|
Mghunium
|
132 |
63K |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
132
|
63K
|
1
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Spenda secures $50m debt warehouse facility
|
|
Mghunium
|
544 |
129K |
7 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
544
|
129K
|
7
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Secondary Trading Notice
|
|
Mghunium
|
44 |
10K |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Sleep Analysis Depressive Burden Study Clinical Trial
|
|
Mghunium
|
29 |
9.5K |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
29
|
9.5K
|
1
|
|
ASX - By Stock
|
ADG |
Re:
Ann: Expanded Exploration Opportunity at Adelong Gold Project
|
|
Mghunium
|
54 |
17K |
4 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
54
|
17K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
VA Deal In US
|
|
Mghunium
|
53 |
24K |
19 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
53
|
24K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
|
|
Mghunium
|
73 |
56K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
73
|
56K
|
0
|
|
ASX - By Stock
|
ADG |
Re:
Ann: Expanded Exploration Opportunity at Adelong Gold Project
|
|
Mghunium
|
54 |
17K |
5 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
54
|
17K
|
5
|
|
ASX - By Stock
|
BCC |
Re:
Ann: Activities Report and Appendix 4C
|
|
Mghunium
|
77 |
20K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
77
|
20K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
Mghunium
|
605 |
233K |
5 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
605
|
233K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
Mghunium
|
605 |
233K |
12 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
605
|
233K
|
12
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Investor Presentation
|
|
Mghunium
|
138 |
42K |
5 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
138
|
42K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
8 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical commences scanning in US at Providence St. Joseph
|
|
Mghunium
|
11 |
6.8K |
5 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
11
|
6.8K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
4 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Mghunium
|
3.0K |
1.2M |
2 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
3.0K
|
1.2M
|
2
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
Mghunium
|
44 |
10K |
1 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
Mghunium
|
44 |
10K |
3 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
44
|
10K
|
3
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: CEO Appointment and Executive Update
|
|
Mghunium
|
58 |
13K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
58
|
13K
|
2
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: CEO Appointment and Executive Update
|
|
Mghunium
|
58 |
13K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
58
|
13K
|
2
|
|